Tapewire

Nasdaq · USD

ZSQR

Z Squared Inc.

Export transactions ↓
Tapewire entity
6495
SEC CIK
0001759186
Parsed reports
89

Last 12 months

Inside the activity.

2 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202620
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 27, 2023 Filed Jan 31, 2023 16:03 UTC
Salkind GeneDirector
GrantNon-qualified Stock Options (right to buy) · Derivative 30,000 Not disclosed Strike: $1.60 Not disclosed
Disclosure

SEC source: 0001683168-23-000434 · ownership.xml · derivative · entry 1

Salkind Gene · CIK 0001592481 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F1 · security: On January 27, 2023, the reporting person received a grant of 30,000 stock options, as non-qualified options, under the 2022 equity incentive plan.

F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant.

F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant.

F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2023, the next 25% vesting on 6/30/2023, the next 25% vesting on 9/30/23, and the final 25% vesting on 12/31/23.

F4 · derivative.expiration_date: Expiration date is ten years from the day of grant.

Read SEC document
January 27, 2023 Filed Jan 31, 2023 10:53 UTC GrantNon-qualified Stock Options (right to buy) · Derivative 30,000 Not disclosed Strike: $1.60 Not disclosed
Disclosure

SEC source: 0001683168-23-000428 · ownership.xml · derivative · entry 1

Deschamps Philippe · CIK 0001638231 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F1 · security: On January 27, 2023, the reporting person received a grant of 30,000 stock options, as non-qualified options, under the 2022 equity incentive plan.

F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant.

F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant.

F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2023, the next 25% vesting on 6/30/2023, the next 25% vesting on 9/30/23, and the final 25% vesting on 12/31/23.

F4 · derivative.expiration_date: Expiration date is ten years from the day of grant.

Read SEC document
January 27, 2023 Filed Jan 31, 2023 16:09 UTC
Yerace Daniel AlexanderDirector · VP of Operations
GrantIncentive Stock Options (right to buy) · Derivative 200,000 Not disclosed Strike: $1.60 Not disclosed
Disclosure

SEC source: 0001683168-23-000438 · ownership.xml · derivative · entry 1

Yerace Daniel Alexander · CIK 0001846625 · Director · VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires not disclosed

F1 · security: On January 27, 2023, the reporting person received a grant of 200,000 incentive stock options, under the 2022 equity incentive plan.

F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant.

F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant.

F3 · derivative.exercise_date: Options will vest over 4 years, with the first 25% vesting on 12/31/23, and the balance vesting in equal quarterly installments over the succeeding three years, with the final options vesting on 12/31/26.

F4 · derivative.expiration_date: Expiration date is ten years from the day of grant.

Read SEC document
January 27, 2023 Filed Jan 31, 2023 16:05 UTC
Sheehy Christine EliseDirector · CFO and Secretary
GrantIncentive Stock Options (right to buy) · Derivative 200,000 Not disclosed Strike: $1.60 Not disclosed
Disclosure

SEC source: 0001683168-23-000436 · ownership.xml · derivative · entry 1

Sheehy Christine Elise · CIK 0001846632 · Director · CFO and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires not disclosed

F1 · security: On January 27, 2023, the reporting person received a grant of 200,000 incentive stock options, under the 2022 equity incentive plan.

F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant.

F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant.

F3 · derivative.exercise_date: Options will vest over 4 years, with the first 25% vesting on 12/31/23, and the balance vesting in equal quarterly installments over the succeeding three years, with the final options vesting on 12/31/26.

F4 · derivative.expiration_date: Expiration date is ten years from the day of grant.

Read SEC document
January 27, 2023 Filed Jan 31, 2023 15:59 UTC
Mehalick DavidDirector · CEO and President · 10% owner
GrantIncentive Stock Options (right to buy) · Derivative 250,000 Not disclosed Strike: $1.76 Not disclosed
Disclosure

SEC source: 0001683168-23-000432 · ownership.xml · derivative · entry 2

Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires not disclosed

F2 · security: On January 27, 2023, the reporting person received a grant of 250,000 incentive stock options, under the 2022 equity incentive plan.

F6 · derivative.exercise_price: The exercise price is equal to 110% of the FMV of the shares on the day of grant.

F6 · price: The exercise price is equal to 110% of the FMV of the shares on the day of grant.

F4 · derivative.exercise_date: Options will vest over 4 years, with the first 25% vesting on 12/31/23, and the balance vesting in equal quarterly installments over the succeeding three years, with the final options vesting on 12/31/26.

F8 · derivative.expiration_date: Expiration date is five years from the day of grant, as the reporting person is a 10% owner and the options are incentive stock options.

F10 · balance_after: Following the exercise of options under both reported transactions, the reporting person will have a total of 625,000 derivative securities beneficially owned.

Read SEC document
January 27, 2023 Filed Jan 31, 2023 15:59 UTC
Mehalick DavidDirector · CEO and President · 10% owner
GrantNon-qualified Stock Options (right to buy) · Derivative 375,000 Not disclosed Strike: $1.60 Not disclosed
Disclosure

SEC source: 0001683168-23-000432 · ownership.xml · derivative · entry 1

Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 375,000

Underlying: Common Stock · 375,000 shares

Expires not disclosed

F1 · security: On January 27, 2023, the reporting person received a grant of 375,000 stock options, as non-qualified options, under the 2022 equity incentive plan.

F5 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant.

F5 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant.

F3 · derivative.exercise_date: Options will vest over 4 years, with the first 25% vesting on 12/31/23, and the balance vesting in equal quarterly installments over the succeeding three years, with the final options vesting on 12/31/26.

F7 · derivative.expiration_date: Expiration date is ten years from the day of grant

F9 · balance_after: Following the exercise of options under both reported transactions, the reporting person will have a total of 625,000 derivative securities beneficially owned.

Read SEC document
January 27, 2023 Filed Jan 31, 2023 15:55 UTC
DeSilva TaraDirector
GrantNon-qualified Stock Options (right to buy) · Derivative 30,000 Not disclosed Strike: $1.60 Not disclosed
Disclosure

SEC source: 0001683168-23-000430 · ownership.xml · derivative · entry 1

DeSilva Tara · CIK 0001952535 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F1 · security: On January 27, 2023, the reporting person received a grant of 30,000 stock options, as non-qualified options, under the 2022 equity incentive plan.

F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant.

F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant.

F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2023, the next 25% vesting on 6/30/2023, the next 25% vesting on 9/30/23, and the final 25% vesting on 12/31/23.

F4 · derivative.expiration_date: Expiration date is ten years from the day of grant.

Read SEC document
January 27, 2023 Filed Jan 31, 2023 15:51 UTC GrantNon-qualified Stock Options (right to buy) · Derivative 30,000 Not disclosed Strike: $1.60 Not disclosed
Disclosure

SEC source: 0001683168-23-000426 · ownership.xml · derivative · entry 1

Cochran Christopher P. · CIK 0001951916 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F1 · security: On January 27, 2023, the reporting person received a grant of 30,000 stock options, as non-qualified options, under the 2022 equity incentive plan.

F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant.

F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant.

F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 4/27/2023, the next 25% vesting on 7/27/2023, the next 25% vesting on 10/27/23, and the final 25% vesting on 1/27/24.

F4 · derivative.expiration_date: Expiration date is ten years from the day of grant.

Read SEC document
January 27, 2023 Filed Jan 31, 2023 15:50 UTC
Calise ChrisDirector
GrantNon-qualified Stock Options (right to buy) · Derivative 30,000 Not disclosed Strike: $1.60 Not disclosed
Disclosure

SEC source: 0001683168-23-000424 · ownership.xml · derivative · entry 1

Calise Chris · CIK 0001824769 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F1 · security: On January 27, 2023, the reporting person received a grant of 30,000 stock options, as non-qualified options, under the 2022 equity incentive plan.

F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant.

F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant.

F3 · derivative.exercise_date: Non-qualified options will vest over 1 year, in four equal installments, with the first 25% vesting on 3/31/2023, the next 25% vesting on 6/30/2023, the next 25% vesting on 9/30/23, and the final 25% vesting on 12/31/23.

F4 · derivative.expiration_date: Expiration date is ten years from the day of grant.

Read SEC document
October 28, 2022 Filed Nov 2, 2022 01:30 UTC
Calise ChrisDirector · 10% owner
Striar Robert10% owner
GrantWarrant · Derivative 3,000,000 $1.00 Strike: $11.50 $3,000,000.00
Disclosure

SEC source: 0001213900-22-068387 · ownership.xml · derivative · entry 1

Bull Horn Holdings Sponsor LLC · CIK 0001759065 · 10% owner

Calise Chris · CIK 0001824769 · Director · 10% owner

Striar Robert · CIK 0001824965 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,000,000

Underlying: Common Stock · 3,000,000 shares

Expires 2027-10-28

F1 · date: On October 28, 2022, Bull Horn Holdings Corp. ("Bull Horn") completed its initial business combination with Coeptis Therapeutics, Inc., a Delaware corporation ("Coeptis"), and changed its name to Coeptis Therapeutics Holdings, Inc., pursuant to that certain Agreement and Plan of Merger, dated as of April 18, 2022.

F2 · kind: Bull Horn Holdings Sponsor LLC (the "Sponsor") acquired these warrants for a purchase price of $1.00 per warrant in connection with the initial public offering of Bull Horn. The warrants could only become eligible for exercise upon consummation of Bull Horn's initial business combination. Since the exercise of the warrants was contingent upon the closing of the business combination, these warrants were not reported at the time of acquisition. The acquisition is being reported now in connection with the consummation of Bull Horn's initial business combination with Coeptis.

F3 · ownership.direct: The Sponsor is the record holder of the warrants reported herein. Christopher Calise and Robert Striar are the managing members of the Sponsor and have voting and dispositive power over the warrants held by the Sponsor. Each of Mr. Calise and Mr. Striar disclaims any beneficial ownership of the reported warrants other than to the extent of any pecuniary interest he may have therein.

Read SEC document
May 04, 2022 Filed May 6, 2022 18:19 UTC SaleOrdinary Shares 85,305 $10.11 $862,433.55
Disclosure

SEC source: 0001567619-22-009708 · doc1.xml · nonDerivative · entry 1

Harraden Circle Investments, LLC · CIK 0001910592 · 10% owner

Harraden Circle Investors GP, LLC · CIK 0001927546 · 10% owner

Harraden Circle Investors GP, LP · CIK 0001927544 · 10% owner

Harraden Circle Investors, LP · CIK 0001700249 · 10% owner

Fortmiller Frederick Vincent Jr. · CIK 0001927576 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 429,131

F1 · ownership.direct: These ordinary shares of the Issuer ("Shares") are directly owned by Harraden Circle Investors, LP ("Harraden Fund"). Harraden Circle Investors GP, LP ("Harraden GP") is the general partner to Harraden Fund, and Harraden Circle Investors GP, LLC ("Harraden LLC") is the general partner of Harraden GP. Harraden Circle Investments, LLC ("Harraden Adviser") serves as investment manager to Harraden Fund. Frederick V. Fortmiller, Jr. ("Mr. Fortmiller") is the managing member of each of Harraden LLC and Harraden Adviser. Each of Harraden GP, Harraden LLC, Harraden Adviser, and Mr. Fortmiller disclaims beneficial ownership of the Shares reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

F1 · ownership.nature: These ordinary shares of the Issuer ("Shares") are directly owned by Harraden Circle Investors, LP ("Harraden Fund"). Harraden Circle Investors GP, LP ("Harraden GP") is the general partner to Harraden Fund, and Harraden Circle Investors GP, LLC ("Harraden LLC") is the general partner of Harraden GP. Harraden Circle Investments, LLC ("Harraden Adviser") serves as investment manager to Harraden Fund. Frederick V. Fortmiller, Jr. ("Mr. Fortmiller") is the managing member of each of Harraden LLC and Harraden Adviser. Each of Harraden GP, Harraden LLC, Harraden Adviser, and Mr. Fortmiller disclaims beneficial ownership of the Shares reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
May 26, 2021 Filed May 26, 2021 21:41 UTC
GLAZER PAUL J10% owner
SaleOrdinary Shares 6,118 $9.85 $60,262.30
Disclosure

SEC source: 0001076809-21-000196 · bhse20210526.xml · nonDerivative · entry 2

GLAZER CAPITAL, LLC · CIK 0001076809 · 10% owner

GLAZER PAUL J · CIK 0001133985 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote 1.

Disclosed balance after: 964,422

F1 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Glazer Capital, LLC, a Delaware limited liability company, serves as investment manager. Mr. Paul J. Glazer serves as the Managing Member of Glazer Capital, LLC. Each of Glazer Capital, LLC and Mr. Paul J. Glazer disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein.

Read SEC document
May 25, 2021 Filed May 26, 2021 21:41 UTC
GLAZER PAUL J10% owner
SaleOrdinary Shares 50,000 $9.85 $492,500.00
Disclosure

SEC source: 0001076809-21-000196 · bhse20210526.xml · nonDerivative · entry 1

GLAZER CAPITAL, LLC · CIK 0001076809 · 10% owner

GLAZER PAUL J · CIK 0001133985 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote 1.

Disclosed balance after: 1,016,500

F1 · ownership.nature: The securities reported herein are held by certain funds and accounts to which Glazer Capital, LLC, a Delaware limited liability company, serves as investment manager. Mr. Paul J. Glazer serves as the Managing Member of Glazer Capital, LLC. Each of Glazer Capital, LLC and Mr. Paul J. Glazer disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein.

Read SEC document
December 14, 2020 Filed Dec 14, 2020 22:11 UTC OtherOrdinary Shares 281,250 $0.00 $0.00
Disclosure

SEC source: 0001213900-20-042569 · ownership.xml · nonDerivative · entry 1

Bull Horn Holdings Sponsor LLC · CIK 0001759065 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,875,000

F2 · kind: Messrs. Robert Striar and Christopher Calise are the managing members of the reporting person and have voting and investment discretion with respect to the securities held by the reporting person. As such, they may be deemed to share beneficial ownership of the ordinary shares held directly by the reporting person.

F3 · shares: As contemplated in connection with the initial public offering of the issuer, 281,250 ordinary shares of the issuer were returned by the reporting person to the issuer for no consideration and cancelled because the underwriters' over-allotment option was not exercised.

F1 · balance_after: These ordinary shares represent ordinary shares held by the reporting person acquired pursuant to a subscription agreement by and between the reporting person and the issuer.

Read SEC document
December 14, 2020 Filed Dec 14, 2020 22:10 UTC
Striar RobertDirector · Chief Executive Officer · 10% owner
OtherOrdinary Shares 281,250 $0.00 $0.00
Disclosure

SEC source: 0001213900-20-042565 · ownership.xml · nonDerivative · entry 1

Striar Robert · CIK 0001824965 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Bull Horn Holdings Sponsor LLC

Disclosed balance after: 1,875,000

F2 · kind: Mr. Robert Striar is a managing member of the Sponsor and has voting and investment discretion with respect to the securities held by the Sponsor. As such, he may be deemed to share beneficial ownership of the ordinary shares held directly by the Sponsor.

F3 · shares: As contemplated in connection with the initial public offering of the issuer, 281,250 ordinary shares of the issuer were returned by the Sponsor to the issuer for no consideration and cancelled because the underwriters' over-allotment option was not exercised.

F1 · balance_after: These ordinary shares represent ordinary shares held by Bull Horn Holdings Sponsor LLC (the "Sponsor") acquired pursuant to a subscription agreement by and between the Sponsor and the issuer.

F2 · ownership.nature: Mr. Robert Striar is a managing member of the Sponsor and has voting and investment discretion with respect to the securities held by the Sponsor. As such, he may be deemed to share beneficial ownership of the ordinary shares held directly by the Sponsor.

Read SEC document
December 14, 2020 Filed Dec 14, 2020 22:08 UTC
Calise ChrisDirector · Chief Financial Officer · 10% owner
OtherOrdinary Shares 281,250 $0.00 $0.00
Disclosure

SEC source: 0001213900-20-042561 · ownership.xml · nonDerivative · entry 1

Calise Chris · CIK 0001824769 · Director · Chief Financial Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Bull Horn Holdings Sponsor LLC

Disclosed balance after: 1,875,000

F2 · kind: Mr. Christopher Calise is a managing member of the Sponsor and has voting and investment discretion with respect to the securities held by the Sponsor. As such, he may be deemed to share beneficial ownership of the ordinary shares held directly by the Sponsor.

F3 · shares: As contemplated in connection with the initial public offering of the issuer, 281,250 ordinary shares of the issuer were returned by the Sponsor to the issuer for no consideration and cancelled because the underwriters' over-allotment option was not exercised.

F1 · balance_after: These ordinary shares represent ordinary shares held by Bull Horn Holdings Sponsor LLC (the "Sponsor") acquired pursuant to a subscription agreement by and between the Sponsor and the issuer.

F2 · ownership.nature: Mr. Christopher Calise is a managing member of the Sponsor and has voting and investment discretion with respect to the securities held by the Sponsor. As such, he may be deemed to share beneficial ownership of the ordinary shares held directly by the Sponsor.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.